RNXT – renovorx, inc. (US:NASDAQ)
Stock Stats
News
RenovoRx to Participate in AlphaNorth Capital Event, January 16-18, 2026
RenovoRx To Announce Promising New Clinical Data Using its TAMP™ Therapy Platform in an Abstract to be Presented at ASCO GI 2026
RenovoRx (NASDAQ:RNXT) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
RenovoRx Announces Acceptance of Clinical Data Abstract at the ASCO Gastrointestinal Cancers Symposium 2026 [Yahoo! Finance]
RenovoRx Announces Acceptance of Clinical Data Abstract at the ASCO Gastrointestinal Cancers Symposium 2026
Form 4 RenovoRx, Inc. For: Dec 31 Filed by: Agah Ramtin
Form 4 RenovoRx, Inc. For: Dec 30 Filed by: Agah Ramtin
Form 8-K RenovoRx, Inc. For: Jan 02
Form 4 RenovoRx, Inc. For: Dec 18 Filed by: Bagai Shaun
Form 4 RenovoRx, Inc. For: Dec 17 Filed by: Bagai Shaun
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.